Disto Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2002.
2002 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Disto Pharmaceuticals Private Limited

Disto Pharmaceuticals Private Limited, a active private limited company, was established on 09 May 2002 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239TG2002PTC038926. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.56 Cr.

It upholds a compliant status. Employing 75 professional, Its leadership includes Asith Kumar Mukherjee (Managing Director), Harish Chandra Pandey (Director), Bidesh Mukherjee (Whole-Time Director). Past directors included Venkata Subramaniswara Rao Kollu, Jyotshna Mohanty, Asith Kumar Mukherjee. It holds ₹18.87 Cr open charges and ₹1.95 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No-22, Phase-I, Cherlapally Industrial Area, Hyderabad, Telangana, 500051.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG2002PTC038926

  • Registration Number

    038926

  • Incorporation Date

    09 May 2002

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹4.56 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 4.56 Cr
  • Company Age 23 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 18.87 Cr
  • Satisfied Charges ₹ 1.95 Cr
  • Revenue Growth **** 71.20%
  • Profit Growth **** 571.78%
  • Ebitda **** 356.67%
  • Net Worth 28.49%
  • Total Assets **** 6.63%
Company report

Disto Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Disto Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Disto Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Asith Kumar Mukherjee Managing Director 15 Sep 2009 Current
Harish Chandra Pandey Director 15 Sep 2009 Current
Bidesh Mukherjee Whole-Time Director 15 Oct 2022 Current
Krishna Raj Pandey Whole-Time Director 15 Oct 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 02 Aug 2010 Past
Pramod Abcsdd Director 08 Feb 2021 Past
Pramod Abcsdd Director 15 May 2010 Past
Pramod Abcsdd Director 31 Oct 2018 Past
Pramod Abcsdd Additional Director 28 Apr 2023 Past
Pramod Abcsdd Additional Director 28 Apr 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Disto Pharmaceuticals.

Disto Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 71.2% increase. The company also saw a substantial improvement in profitability, with a 571.78% increase in profit. The company's net worth Soared by an impressive increase of 28.49%.

Disto Pharmaceuticals revenue growth over time
Disto Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 71.20%
*******
*******
*******
*******
Revenue from Operations
*******
 70.07%
*******
*******
*******
*******
Total Assets
*******
 6.63%
*******
*******
*******
*******
Profit or Loss
*******
 571.78%
*******
*******
*******
*******
Net Worth
*******
 28.49%
*******
*******
*******
*******
EBITDA
*******
 356.67%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Disto Pharmaceuticals?

Unlock access to Disto Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹188,686,721.00

Satisfied Charges

₹19,450,000.00

Charges Breakdown by Lending Institutions
  • Uco Bank : 18.06 Cr
  • Hdfc Bank Limited : 0.81 Cr
Latest Charge Details
Date Lender Amount Status
09 Oct 2025 Uco Bank ₹9.61 Cr Open
03 Dec 2024 Uco Bank ₹8.40 M Open
18 Sep 2024 Uco Bank ₹1.18 M Open
05 Jul 2024 Hdfc Bank Limited ₹1.75 M Open
28 May 2024 Hdfc Bank Limited ₹2.21 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Disto Pharmaceuticals?

Disto Pharmaceuticals has a workforce of 75 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Disto Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Disto Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Disto Pharmaceuticals
Recent Activity within the Organization
  • Charges

    Progress on A charge with Uco Bank amounted to Rs. 9.61 Cr with Charge ID 101171460 was registered on 09 Oct 2025. was documented.

  • Charges

    The activity A charge with Uco Bank amounted to Rs. 0.84 Cr with Charge ID 101054918 was registered on 03 Dec 2024. was completed.

  • Annual General Meeting

    The activity Disto Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Charges

    A charge with Uco Bank amounted to Rs. 0.12 Cr with Charge ID 100982787 was registered on 18 Sep 2024. was recorded as a recent event.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 0.18 Cr with Charge ID 100970273 was registered on 05 Jul 2024. was completed.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.22 Cr with Charge ID 100949760 was registered on 28 May 2024. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Disto Pharmaceuticals Private Limited?

The CIN of Disto Pharmaceuticals Private Limited is U24239TG2002PTC038926.

Where is Disto Pharmaceuticals Private Limited headquartered?

Disto Pharmaceuticals Private Limited is headquartered at Plot No-22, Phase-I, Cherlapally Industrial Area, Hyderabad, Telangana, 500051.

When was Disto Pharmaceuticals Private Limited incorporated?

Disto Pharmaceuticals Private Limited was incorporated on 09 May 2002.

Who are the current directors of Disto Pharmaceuticals Private Limited?

The current directors of Disto Pharmaceuticals Private Limited are

What is the primary industry of Disto Pharmaceuticals Private Limited?

The primary industry of Disto Pharmaceuticals Private Limited is Manufacturing.

Is Disto Pharmaceuticals Private Limited a listed company?

Disto Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Disto Pharmaceuticals Private Limited?

The authorized capital of Disto Pharmaceuticals Private Limited is ₹5.00 Cr, and the paid-up capital is ₹4.56 Cr.

What is the compliance status of Disto Pharmaceuticals Private Limited?

The compliance status of Disto Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available